Usage : Soranib Tablet is used in the treatment of Liver cancer,Kidney cancer,Thyroid cancer.
We are recognized as the foremost exporter, wholesaler and supplier of Soranib - Sorafenib 200mg Tablets (Cipla). These tablets are specifically formulated for the treatment of primary kidney cancer and major liver cancer. Furthermore, we sourced these tablets from the reliable vmore...
Demega formulations India is a major exporter of Sorafenib Tablets is used to treat advanced renal cell carcinoma . also to treat unresectable hepatocellular carcinoma Soranib works by slowing the spread of cancer cells. more...
Usage : Soranib Tablet belongs to the class of medicines known as tyrosine kinase inhibitors used in the treatment of liver cancer, kidney cancer, and thyroid cancer.
Product Name : Soranib Tablet
Color : white
Country of Origin : India
Soranib Tablet belongs to the class of medicines known as tyrosine kinase inhibitors used in the treatment of liver cancer, kidney cancer, and thyroid cancer.more...
Description : Sorafenat 200 mg tablet is used in the treatment of kidney cancer, thyroid cancer and liver cancer.Sorafenat 200 mg tablet In patients with cancer, a change in DNA triggers a signal which produces abnormal cancer cells.
Contact us, if you are looking for Soranib Tablets at the best market rates. We are associated with trustworthy manufacturers who formulate these medicines under favorable conditions using superlative grade chemical compounds and sophisticated technology. Our Soranib Tablets are more...
Sorafenib Tablets IP belongs to the class of medicines known as tyrosine kinase inhibitors used in the treatment of liver cancer, kidney cancer, and thyroid cancer.more...
FDA grants regular approval to sacituzumab govitecan for triple-negative breast cancer.On April 7, 2021, the Food and Drug Administration granted regular approval to sacituzumab govitecan (Trodelvy, Immunomedics Inc.) for patients with unresectable locally advanced or metastatic more...
sorafenib 200 mg is used kinase inhabitor drug approved for the treatment of kidney cancer and advance primary liver cancer available at the rate of 4500 for 120 tabmore...